# OnCo record nct06952803 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06952803/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06952803", "NCT06952803" ;
  schema:name "A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation"@en ;
  schema:alternateName "EvoPAR-Prostate02"@en ;
  schema:description "A phase 3 trial testing Saruparib in prostate cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06952803/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06952803> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-08-06" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:drugs <https://onco.cc/drugs/saruparib/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .